Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 3
2(50.0%)
4Total
Phase 2(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04703673Completed

Sinolpan® Pharmacy Non-interventional Study - Quality of Live

Role: lead

NCT01340690Phase 3Terminated

Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder

Role: collaborator

NCT02396706Phase 2Completed

RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough

Role: lead

NCT01127048Phase 3Unknown

Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children

Role: lead

NCT01227759Phase 2Completed

Tyrosur® Gel-Investigation on Wound Healing Efficacy

Role: lead

All 5 trials loaded